17 research outputs found
Gαq activation modulates autophagy by promoting mTORC1 signaling.
The mTORC1 node plays a major role in autophagy modulation. We report a role of the ubiquitous Gαq subunit, a known transducer of plasma membrane G protein-coupled receptors signaling, as a core modulator of mTORC1 and autophagy. Cells lacking Gαq/11 display higher basal autophagy, enhanced autophagy induction upon different types of nutrient stress along with a decreased mTORC1 activation status. They are also unable to reactivate mTORC1 and thus inactivate ongoing autophagy upon nutrient recovery. Conversely, stimulation of Gαq/11 promotes sustained mTORC1 pathway activation and reversion of autophagy promoted by serum or amino acids removal. Gαq is present in autophagic compartments and lysosomes and is part of the mTORC1 multi-molecular complex, contributing to its assembly and activation via its nutrient status-sensitive interaction with p62, which displays features of a Gαq effector. Gαq emerges as a central regulator of the autophagy machinery required to maintain cellular homeostasis upon nutrient fluctuations.We thank Paula Ramos, Susana Rojo-Berciano, and Laura LĂłpez for helpful technicalassistance. Dr. Marta Cruces (Universidad AutĂłnoma de Madrid, Spain) for herinvaluable help regarding the liver explants experiments, Dr. Badford Berk (University ofRochester, NY, USA) for providing the GFP-Flag-PB1-p62 plasmid, Drs. Stefan Offer-manns and Nina Wettschureck (Max-Planck-Institute for Heart and Lung Research,Germany) for providing Tie2-CreERT2; Gnaq f/f; Gna11â/â[EC-q/11-KO) mice, andDr. GuzmĂĄn SĂĄnchez for scientific advice. We thank also Ricardo Ramos from theGenomic facility of FundaciĂłn Parque CientĂfico de Madrid (Universidad AutĂłnoma deMadrid, Spain) and Gemma RodrĂguez-Tarduchy from the Genomic facility of theInstituto de Investigaciones BiomĂ©dicasâAlberto Solsâfor their help with cell linesauthentication. The help from CBMSO Animal Care, Flow Cytometry, Electron andOptical and Confocal Microscopy facilities is also acknowledged. This work was sup-ported by Ministerio de EconomĂa; Industria y Competitividad (MINECO) of Spain(grant SAF2017-84125-R to F.M.), (grant BFU2017-83379-R to A.M.A.), Instituto deSalud Carlos III (PI18/01662 to CR, co-funded with European FEDER contribution),CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co-fundedwith European FEDER contribution), FundaciĂłn RamĂłn Areces (to C.R. and F.M.) andPrograma de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M. and NIH grants AG021904 and AG038072 to A.M.C. Wealso acknowledge the support of a Contrato para la FormaciĂłn del Profesorado Uni-versitario (FPU13/04341) and (FPU14/06670), an EMBO short-term fellowship (ASTF600-2016). We also acknowledge institutional support to the CBMSO from FundaciĂłnRamĂłn Areces.S
Protein kinase C ζ interacts with a novel binding region of Gαq to act as a functional effector
Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that GPCR activation promotes a direct interaction between Gαq and protein kinase C ζ (PKCζ), leading to the stimulation of the ERK5 pathway independent of the canonical effector PLCÎČ. We report herein that the activation-dependent Gαq/PKCζ complex involves the basic PB1-type II domain of PKCζ and a novel interaction module in Gαq different from the classical effector-binding site. Point mutations in this Gαq region completely abrogate ERK5 phosphorylation, indicating that Gαq/PKCζ association is required for the activation of the pathway. Indeed, PKCζ was demonstrated to directly bind ERK5 thus acting as a scaffold between Gαq and ERK5 upon GPCR activation. The inhibition of these protein complexes by G proteincoupled receptor kinase 2, a known Gαq modulator, led to a complete abrogation of ERK5 stimulation. Finally, we reveal thatGαq/ PKCζ complexes link Gαq to apoptotic cell death pathways. Our data suggest that the interaction between this novel region in Gαq and the effector PKCζ is a key event in Gαq signaling.Ministerio de EducaciĂłn y Ciencia (SAF2011-23800, SAF2014-55511-R), FundaciĂłn RamĂłn Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332), and Instituto de Salud Carlos III (PI11/00126, PI14/00201) (to F. M. and C. R.). This work was also supported in part by the NIGMS, National Institutes of Health Grant R01-GM088242 (to G. T.), the Canadian Institutes of Health Research (CIHR) (MOP-GMX-231013) (to S. M.), an EMBO Short Fellowship (to G. S. F.), and Fondo Europeo de Desarrollo Regional (FEDER, European Union)Peer Reviewe
BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery
Aims
TGF-Ă regulates tissue fibrosis: TGF-Ă promotes fibrosis, whereas bone morphogenetic protein (BMP)-7 is antifibrotic. To demonstrate that (i) left ventricular (LV) remodelling after pressure overload is associated with disequilibrium in the signalling mediated by these cytokines, and (ii) BMP-7 exerts beneficial effects on LV remodelling and reverse remodelling.
Methods and results
We studied patients with aortic stenosis (AS) and mice subjected to transverse aortic constriction (TAC) and TAC release (de-TAC). LV morphology and function were assessed by echocardiography. LV biopsies were analysed by qPCR, immunoblotting, and histology. Pressure overload reduced BMP-7 and pSmad1/5/8 and increased TGF-Ă and pSmad2/3 in AS patients and TAC mice. BMP-7 correlated inversely with collagen, fibronectin, and Ă-MHC expressions, and with hypertrophy and diastolic dysfunction, and directly with the systolic function. Multiple linear regression disclosed BMP-7 and TGF-Ă as hypertrophy predictors, negative and positive, respectively. BMP-7 prevented TGF-Ă-elicited hypertrophic program in cardiomyocytes, and Col1A1 promoter activity in NIH-3T3 fibroblasts. The treatment of TAC mice with rBMP-7 attenuated the development of structural damage and dysfunction, and halted ongoing remodelling. The reverse remodelling after pressure overload release was facilitated by rBMP-7, and hampered by disrupting BMP-7 function using a neutralizing antibody or genetic deletion.
Conclusion
The disequilibrium between BMP-7 and TGF-Ă signals plays a relevant role in the LV remodelling response to haemodynamic stress in TAC mice and AS patients. Our observations may provide new important insights aimed at developing novel therapies designed to prevent, halt, or reverse LV pathological remodelling in pressure overload cardiomyopathy
CryoEM of RUVBL1-RUVBL2-ZNHIT2, a complex that interacts with pre-mRNA-processing-splicing factor 8.
Biogenesis of the U5 small nuclear ribonucleoprotein (snRNP) is an essential and highly regulated process. In particular, PRPF8, one of U5 snRNP main components, requires HSP90 working in concert with R2TP, a cochaperone complex containing RUVBL1 and RUVBL2 AAA-ATPases, and additional factors that are still poorly characterized. Here, we use biochemistry, interaction mapping, mass spectrometry and cryoEM to study the role of ZNHIT2 in the regulation of the R2TP chaperone during the biogenesis of PRPF8. ZNHIT2 forms a complex with R2TP which depends exclusively on the direct interaction of ZNHIT2 with the RUVBL1-RUVBL2 ATPases. The cryoEM analysis of this complex reveals that ZNHIT2 alters the conformation and nucleotide state of RUVBL1-RUVBL2, affecting its ATPase activity. We characterized the interactions between R2TP, PRPF8, ZNHIT2, ECD and AAR2 proteins. Interestingly, PRPF8 makes a direct interaction with R2TP and this complex can incorporate ZNHIT2 and other proteins involved in the biogenesis of PRPF8 such as ECD and AAR2. Together, these results show that ZNHIT2 participates in the assembly of the U5 snRNP as part of a network of contacts between assembly factors required for PRPF8 biogenesis and the R2TP-HSP90 chaperone, while concomitantly regulating the structure and nucleotide state of R2TP.Agencia Estatal de InvestigaciĂłn (AEI/10.13039/501100011033), Ministerio de Ciencia e InnovaciĂłn and co-funded by the European Regional Development Fund (ERDF-UE) [SAF2017-82632-P and PID2020-114429RB-I00 to O.L.]; Autonomous Region of Madrid and co-funded by the European Social Fund and the European Regional Development Fund [Y2018/BIO4747 and P2018/NMT4443 to O.L., and which support the contracts of S.C. and A.G-C.]; Funding for open access charge: Agencia Estatal de InvestigaciĂłn (AEI/10.13039/501100011033), Ministerio de Ciencia e InnovaciĂłn, co-funded by the European Regional Development Fund (ERDF-UE) [SAF2017-82632-P to O.L.]; S.C. contract is funded by the CNIO Friends Program philanthropic initiative since June 2021.S
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus. However, boosting innate responses may represent an innovative way to immediately fight future emerging viral infections or boost vaccines. MV130 is a mucosal immunotherapy, based on a mixture of whole heat-inactivated bacteria, that has shown clinical efficacy against recurrent viral respiratory infections. Herein, we show that the prophylactic intranasal administration of this immunotherapy confers heterologous protection against SARS-CoV-2 infection in susceptible K18-hACE2 mice. Furthermore, in C57BL/6 mice, prophylactic administration of MV130 improves the immunogenicity of two different COVID-19 vaccine formulations targeting the SARS-CoV-2 spike (S) protein, inoculated either intramuscularly or intranasally. Independently of the vaccine candidate and vaccination route used, intranasal prophylaxis with MV130 boosted S-specific responses, including CD8+-T cell activation and the production of S-specific mucosal IgA antibodies. Therefore, the bacterial mucosal immunotherapy MV130 protects against SARS-CoV-2 infection and improves COVID-19 vaccines immunogenicity.CF was supported by AECC Foundation (INVES192DELF) and is currently funded by the Miguel Servet program (ID: CP20/00106) (ISCIII). IH-M receives the support of a fellowship from la Caixa Foundation (ID 100010434, fellowship code: LCF/BQ/IN17/11620074) and from the European Unionâs Horizon 2020 research and innovation program under the Marie SkĆodowska-Curie grant agreement no. 713673. AJ-C is a postgraduate fellow of the City Council of Madrid at the Residencia de Estudiantes (2020â2021). GD is supported by an European Molecular Biology Organization (EMBO) Long-term fellowship (ALTF 379-2019). This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie SkĆodowska-Curie grant agreement No. Project number 892965. OL and JA-C acknowledge Comunidad de Madrid (Tec4Bio-CM, S2018/NMT-4443, FEDER). Work in OL laboratory was funded by CNIO with the support of the projects Y2018/BIO4747 and P2018/NMT4443 from Comunidad de Madrid and co-funded by the European Social Fund and the European Regional Development Fund. The CNIO is supported by the Instituto de Salud Carlos III (ISCIII). Work at CNB and CISA is funded by the Spanish Health Ministry, Instituto de Salud Carlos III (ISCIII), Fondo COVID-19 grant COV20/00151, and Fondo Supera COVID-19 (Crue Universidades-Banco Santander) (to JG-A). Work in the DS laboratory is funded by the CNIC; by the European Research Council (ERC-2016-Consolidator Grant 725091); by Agencia Estatal de InvestigaciĂłn (PID2019-108157RB); by Comunidad de Madrid (B2017/BMD-3733 Immunothercan-CM); by Fondo Solidario Juntos (Banco Santander); by a research agreement with Inmunotek S.L.; and by FundaciĂł La MaratĂł de TV3 (201723). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICINN, and the Pro CNIC Foundation.Peer reviewe
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic
Gαq is a novel modulator of autophagy
Tesis Doctoral inĂ©dita leĂda en la Universidad AutĂłnoma de Madrid, Facultad de Ciencias, Departamento de BiologĂa Molecular. Fecha de lectura: 20-07-2018Esta tesis tiene embargado el acceso al texto completo hasta el 20-01-2020The highly conserved autophagy processes play a central role in cellular homeostasis by allowing the
lysosomal degradation of cellular components either in basal conditions or in response to fluctuations in
the internal or external microenvironment, thus helping to adapt to different stress situations. Autophagy
is regulated in a cell-autonomous fashion mainly through AMP-activated protein kinase (AMPK) and mammalian
target or rapamycin complex 1 (mTORC1) modulators. Recent studies suggest that nutrients may
also modulate autophagy in a systemic manner through different nutrient-sensing receptors, and emerging
evidence suggest that members of the G protein-coupled receptors (GPCRs) membrane receptor family
could play such a role. These GPCR nutrient receptors act via different G proteins, including Gαq/11. In
this work, we unveil an unanticipated role of Gαq/11 as a key component of the cellular nutrient-sensing
machinery. Cells lacking Gαq/11 display higher basal autophagy and an earlier and prolonged induction of
this process upon serum removal or in the absence of amino acids or glucose, suggesting that Gαq/11 acts
as a general sensor of nutrient availability. Moreover, we describe the presence of Gαq in lysosomal and
autophagic compartments and a dynamic redistribution of Gαq between autophagic vacuoles upon nutrient
deprivation. However, Gαq is not a substrate of autophagy under nutrient stress conditions, consistent with
a role as an autophagy modulator. Importantly, we demonstrate that Gαq affects autophagy processes via the
modulation of the key mTORC1 signaling hub, and identify p62/SQSTM1 as the effector linking Gαq/11 to
the activation of mTORC1 via the formation of Gαq/p62/mTORC1 multi-molecular complexes. We find that
p62 displays most of the features of a bona fide Gαq effector and that these proteins associate through a
PB1-like interaction, involving the PB1 domain of p62 and the acidic PB1-binding region of Gαq. The dynamic
formation of Gαq/p62 complexes in the presence of nutrients contributes to the activation of mTORC1, thus
allowing the subsequent inactivation of macroautophagy in these metabolic conditions. Interestingly, we
show that Gαq/11 is also required for the proper lysosomal positioning upon nutrient starvation or recovery,
suggesting a role for Gαq/11 in the coordination of mTORC1 activation and lysosomal trafficking processes.
On the other hand, Gαq localizes in lysosomes enriched in chaperone-mediated autophagy (CMA) and appears
to positively modulate this process in both basal and prolonged starvation conditions. Our results postulate
Gαq as a central molecular switch between different autophagic pathways, thus helping to maintain cellular
homeostasis upon nutrient fluctuations
ERK5 Activation by Gq-Coupled Muscarinic Receptors is Independent of Receptors Iternalization and beta-Arrestin Recruitment
This work was funded by the Ministerio de Ciencia e Innovacion (MICINN) grants (SAF2008-00211; PIE- 200820I166), and a grant from the Spanish Comunidad de Madrid CCG08-CSIC/SAL-3464. G-protein-coupled receptors (GPCRs) are known to activate both G protein- and ÎČ -arrestin-dependent signalling cascades. The initiation of mitogen-activated protein kinase (MAPK) pathways is a key downstream event in the control of cellular functions including proliferation, differentiation, migration and apoptosis. Both G proteins and ÎČ-arrestins have been reported to mediate context-specific activation of ERK1/2, p38 and JNK MAPKs. Recently, the activation of ERK5 MAPK by Gq-coupled receptors has been described to involve a direct interaction between G αqand two novel effectors, PKCζ and MEK5. However, the possible contribution of ÎČ-arrestin towards this pathway has not yet been addressed. In the present work we sought to investigate the role of receptor internalization processes and ÎČ-arrestin recruitment in the activation of ERK5 by Gq-coupled GPCRs. Our results show that ERK5 activation is independent of M1 or M3 muscarinic receptor internalization. Furthermore, we demonstrate that phosphorylation-deficient muscarinic M1 and M3 receptors are still able to fully activate the ERK5 pathway, despite their reported inability to recruit ÎČ-arrestins. Indeed, the overexpression of Gαq, but not that of ÎČ-arrestin1 or ÎČ-arrestin2, was found to potently enhance ERK5 activation by GPCRs, whereas silencing of ÎČ-arrestin2 expression did not affect the activation of this pathway. Finally, we show that a ÎČ-arrestin-biased mutant form of angiotensin II (SII; Sar1-Ile4-Ile8AngII) failed to promote ERK5 phosphorylation in primary cardiac fibroblasts, as compared to the natural ligand. Overall, this study shows that the activation of ERK5 MAPK by model Gq-coupled GPCRs does not depend on receptor internalization, ÎČ-arrestin recruitment or receptor phosphorylation but rather is dependent on Gαq-signalling.The study was funded by grants from Ministerio de EducaciĂłn y Ciencia (SAF2011-23800), FundaciĂłn RamĂłn Areces, The Cardiovascular Diseases Network of Ministerio Sanidad y Consumo-Instituto Carlos III (RD12/0042/0012), Comunidad de Madrid (S-2011/BMD-2332) and Instituto de Salud Carlos III (PI11/00126). Collaboration with Dr. Andrew Tobin was possible thanks to a Wood-Whelan Research Felowship (IUMBM) awarded to GSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Peer Reviewe
SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1a complex in vascular endothelial cellsÂ
Resumen del trabajo presentado al International Symposium on Redox Signaling and Oxidative Stress in Health and Disease, IV Spanish and Portuguese Meeting on Free Radicals; celebrado en Valencia (España) del 5 al 7 de junio de 2012.Excessive production of reactive oxygen species (ROS) contributes to progression of
atherosclerosis, at least in part by causing endothelial dysfunction and inflammatory
activation. SirT1 is a class III histone deacetylase that has been implicated in metabolic
and ROS control. In the vasculature, decreased endothelial SirT1 expression increases
endothelial superoxide production, NF-ÎșB signaling, and expression of adhesion molecules. However, the mechanisms that mediate SirT1 function on the endothelium
remain to be characterized. FoxO3a and PGC-1a have been shown to be molecular targets of SirT1 and to control endothelial ROS production. Here we investigated SirT1 regulation of antioxidant genes in vascular endothelial cells and the role played by FoxO3a and PGC-1a in this regulation. We found that SirT1 regulates the expression of several antioxidant genes in BAEC, including MnSOD, catalase, Prx3, Prx5, UCP-2, Trx2 and TR, and can be localized in the regulatory regions of these genes. We also found that knockdown of either FoxO3a or PGC-1a prevented SirT1 antioxidant gene induction. Furthermore, SirT1 increased the formation of a FoxO3a PGC-1a complex as determined by co-IP assays, concomitantly reducing H2O2 dependent FoxO3a and PGC-1a acetylation. Data showing that FoxO3a knockdown increases PGC-1a acetylation levels and vice versa, suggests that SirT1 activity on FoxO3a and PGC-1a may be dependent of the formation of a FoxO3a/PGC-1a complex. In conclusion, we show that SirT1 regulation of antioxidant genes in vascular endothelial cells depends of the formation of a FoxO3a/PGC-1a complex.Peer Reviewe
SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex
SirT1 is a class III histone deacetylase that has been implicated in metabolic and reactive oxygen species control. In the vasculature it has been shown to decrease endothelial superoxide production, prevent endothelial dysfunction and atherosclerosis. However, the mechanisms that mediate SirT1 antioxidant functions remain to be characterized. The transcription factor FoxO3a and the transcriptional coactivator peroxisome proliferator activated receptor Îł-coactivator 1α (PGC-1α) have been shown to induce the expression of antioxidant genes and to be deacetylated by SirT1. Aims: Here we investigated SirT1 regulation of antioxidant genes and the roles played by FoxO3a and PGC-1α in this regulation. Results: We found that SirT1 regulates the expression of several antioxidant genes in bovine aortic endothelial cells, including Mn superoxide dismutase (MnSOD), catalase, peroxiredoxins 3 and 5 (Prx3, Prx5), thioredoxin 2 (Trx2), thioredoxin reductase 2 (TR2), and uncoupling protein 2 (UCP-2) and can be localized in the regulatory regions of these genes. We also found that knockdown of either FoxO3a or PGC-1α prevented the induction of antioxidant genes by SirT1 over-expression. Furthermore, SirT1 increased the formation of a FoxO3a/PGC-1α complex as determined by co-immunoprecipitation (IP) assays, concomitantly reducing H2O2-dependent FoxO3a and PGC-1α acetylation. Data showing that FoxO3a knockdown increases PGC-1α acetylation levels and vice versa, suggest that SirT1 activity on FoxO3a and PGC-1α may be dependent of the formation of a FoxO3a/PGC-1α complex. Innovation: A unifying mechanism for SirT1 activities is suggested. Conclusion: We show that SirT1 regulation of antioxidant genes in vascular endothelial cells depends on the formation of a FoxO3a/PGC-1α complex.Ministerio de EconomĂa y Competitividad (España)Comunidad de MadridDepto. de BiologĂa CelularFac. de Ciencias BiolĂłgicasTRUEpu